ArticleJournal of clinical medicine2022
Treating with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Accompanying Lower Incidence of Second Primary Cancers.
Wen-Ru Chou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.